Business Conference

I want to acquire, sell or diligence an asset or business

Tech Background.png

schedule of services

BCVG has capabilities to drive all aspects of the transaction process:

Due Diligence

Asset identification and competitive assessment

Scientific, clinical & regulatory review

Quality and reimbursement analysis

Channel checks and KOL perspectives

Financial modeling and forecasting

Transaction Services

Investor and partner identification and outreach

Pitch deck and marketing material preparation

Term sheet construction

Deal negotiations

Contract reviews

How we leverage
integrated Insights™ 

BCVG believes input and perspectives from all operational functions is essential for due diligence, positioning assets for sale and valuating assets for purchase.

 

 This holistic approach separates BCVG from many other consulting firms that focus on a single business discipline.

Plan A Chart.png
Tech Background.png

WHAT OUR CLIENT partners ARE SAYING

Kevin
CEO, Orthopaedic OEM

BCVG's thorough, cross-functional diligence guided our decision to successfully acquire a significant new asset. Their approach to partnering with our internal team was flexible and seamless.

Peter
Managing Partner, PE Firm

BCVG's domain expertise and insights guided us, fortunately, NOT to invest in an asset. Their predictions regarding changes in the regulatory and competitive landscape all came true, saving us hundreds of millions of dollars on what would have become a terrible investment.

Stephanie
Sr VP R&D, Orthopaedic OEM

BCVG's understanding of the market, FDA regulations, and competency of industry players governed the design of multiple product development agreements with tissue banks and other business to business suppliers.

DEAL sheet

Transaction Support for Strategics

$500MM+

acquisition of a

private U.S. spinal implant firm

$400MM+

acquisition of private U.S. biomaterial

implant firm

$50MM+

acquisition of a

private U.S. biotech company

$50MM+

acquisition of a public OUS orthobiologic business

Transaction Support for Private Equity

$350MM+

acquisition of a

private U.S. biomaterial firm

$150MM+

acquisition of a

U.S. spine

company

$100MM+

acquisition of a

U.S. spine

company

$50MM+

acquisition of an

orthopaedic implant

firm

Product Development, Distribution and License Agreements

Allograft-based regeneration products for orthopaedic firms

Collagen-based regeneration products for orthopaedic firms

Bioactive factor-based regeneration products for orthopaedic firms

Cell-based regeneration products for orthopaedic and wound care firms

Allograft-and xenograft-based products for wound care firms

Tech Background.png

Learn more about how BCVG can facilitate diligence or a transaction for your business